Cell cycle inhibitory effects of HIV and SIV Vpr and Vpx in the yeast Schizosaccharomyces pombe

Virology

Volumn 230, Issue 1, 1997, Pages 103-112

  Zhang, Chengsheng ^a   Rasmussen, Colin ^a   Chang, Lung Ji ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; GENETIC ANALYSIS; GROWTH INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; MODEL; NONHUMAN; PRIORITY JOURNAL; SCHIZOSACCHAROMYCES POMBE; SIMIAN IMMUNODEFICIENCY VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; MAMMALIA; SCHIZOSACCHAROMYCES POMBE; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0031592602     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8459     Document Type: Article

References (37)

1. Aldrovandi G. M., Zack J. A. Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice. J. Virol. 70:1996;1505-1511.
2. Alfa C., Fantes P., Hyams J., McLeod M., Warbrick E. Experiments with Fission Yeast - A Laboratory Manual. 1992;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
3. Atherton-Fessler S., Parker L. L., Geahlen R. L., Piwnica-Worms H. Mechanism of p34/cdc2 regulation. Mol. Cell. Biol. 13:1993;1675-1685.
4. Bartz S. R., Rogel M. E., Emerman M. Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control. J. Virol. 70:1996;2324-2331.
5. Broek D., Bartlett R., Crawford K., Nurse P. Involvement of p34/cdc2. Nature. 349:1991;388-393.
6. Bukrinsky M. I., Haggerty S., Dempsey M. P., Sharova N., Adzhubei A., Spitz L., Lewis P., Goldfarb D., Emerman M., Stevenson M. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature. 365:1993;666-669.
7. Cohen E. A., Dehni G., Sodroski J. G., Haseltine W. A. Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J. Virol. 64:1990;3097-3099.
8. Desrosiers R. C. The simian immunodeficiency viruses. Ann. Rev. Immunol. 8:1990;557-578.
9. Draetta G., Bizuela L., Potashkin J., Beach D. Identification of p34 and p13, human homologs of the cell cycle regulators of fission yeast encoded by cdc2+ and suc1+. Cell. 50:1987;319-325.
10. Fletcher T. M., Brichacek B., Sharova N., Newman M. A., Stivahtis G., Sharp P. M., Emerman M., Hahn B. H., Stevenson M. Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIVsm. EMBO J. 15:1996;6155-6165.
11. Franchini G., Reitz J. M. S. Phylogenesis and genetic complexity of the nonhuman primate retroviridae. AIDS Res. Human Retroviruses. 10:1994;1047-1060.
12. Gibbs J. S., Lackner A. A., Lang S. M., Simon M. A., Sehgal P. K., Daniel M. D., Desrosiers R. C. Progression to AIDS in the absence of a gene for vpr or vpx. J. Virol. 69:1995;2378-2383.
13. Hayles J., Fisher D., Woollard A., Nurse P. Temporal order of S phase and mitosis in fission yeast is determined by the state of the p34/cdc2. Cell. 78:1994;813-822.
14. He J., Choe S., Walker R., Di Marzio P., Morgan D. O., Landau N. R. Human immunodeficiency virus type 1 viral protein R (vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34/cdc2. J. Virol. 69:1995;6705-6711.
15. Heinzinger N. K., Bukinsky M. I., Haggerty S. A., Ragland A. M., Kewalramani V., Lee M., Gendelman H. E., Ratner L., Stevenson M., Emerman M. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA. 91:1994;7311-7315.
16. Jowett J. B., Planelles V., Poon B., Shah N. P., Chen M.-L., Chen L. S. The human immunodeficiency virus type 1 vpr gene arrests infected cells in the G2 + M phase of the cell cycle. J. Virol. 69:1995;6304-6313.
17. Kinoshita N., Ohkura H., Yanagida M. Distinct, essential roles of type 1 and 2A protein phosphatases in the control of the fission yeast cell division cycle. Cell. 63:1990;403-415.
18. Lang S. M., Weeger M., Stahl-Hennig C., Coulibaly C., Hunsmann G., Muller J., Muller-Hermelink H., Fuchs D., Wachter H., Daniel M. M., Derosiers R. C., Fleckenstein B. Importance of vpr for infection of Rhesus monkeys with simian immunodeficiency virus. J. Virol. 67:1993;902-912.
19. Levy D. N., Fernandes L. S., Williams W. V., Weiner D. B. Induction of cell differentiation by human immunodeficiency virus 1vpr. Cell. 72:1993;541-550.
20. Levy J. A. Pathogenesis of Human Immunodeficiency Virus infection. Microb. Rev. 57:1995;183-289.
21. Macreadie I. G., Castelli L. A., Hewish D. R., Kirkpatrick A., Ward A. C., Azad A. A. A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motifs causes cell growth arrest and structural defects. Proc. Natl. Acad. Sci. USA. 92:1995;2770-2774.
22. Marzio P. D., Choe S., Ebright M., Knoblauch R., Landau N. R. Mutational analysis of cell cycle arrest, nuclear localization, and virion packaging of human immunodeficiency virus type 1 Vpr. J. Virol. 69:1995;7909-7916.
23. Maundrell K. nmt1. J. Biol. Chem. 265:1990;10857-10864.
24. Moreno S., Hayles J., Nurse P. Molecular Genetic Analysis of Fission YeastSchizosaccharomyces pombe. Methods Enzymol. 194:1991;795-823.
25. Nurse P. Ordering S phase and M phase in the cell cycle. Cell. 79:1994;547-550.
26. Paxton W. R., Connor R. I., Landau N. R. Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirements for the p6 region of gag and mutational analysis. J. Virol. 67:1993;7229-7237.
27. Planelles V., Jowett J. B. M., Li Q.-X., Xie Y., Hanh B., Chen I. S. Y. Vpr-induced cell cycle arrest is conserved among primate lentiviruses. J. Virol. 70:1996;2516-2524.
28. Rasmussen C., Rasmussen G. Inhibition of G(2)/M progression inSchizosaccharomyces pombe. Mol. Biol. Cell. 5:1994;785-795.
29. Re F., Braaten D., Franke E. K., Luban J. Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34/cdc2. J. Virol. 69:1995;6859-6864.
30. Rogel M. E., Wu L. I., Emerman M. The human immunodeficiency virus type 1vpr. J. Virol. 69:1995;882-888.
31. Subbramanian R. A., Cohen E. A. Molecular biology of the human immunodeficiency virus accessory proteins. J. Virol. 68:1994;6831-6835.
32. Tristem M., Marshall C., Karpas A., Hill F. Evolution of the primate lentiviruses: evidence from vpx and vpr. EMBO J. 11:1992;3405-3412.
33. Trono D. HIV accessory proteins: leading roles for the supporting cast. Cell. 82:1995;189-192.
34. Vaishnav Y. N., Wong-Staal F. The biochemistry of AIDS. Ann. Rev. Biochem. 60:1991;577-630.
35. Wera S., Fernandez A., Lamb N. J. C., Turowski P., Hemmings-Mieszczak M., Mayer-Jaekel R. E., Hemmings B. A. Deregulation of translational control of the 65-kDa regulatory subunit (PR65a) of protein phosphatase 2A leads to multinucleated cells. J. Biol. Chem. 270:1995;21374-21381.
36. Yu X. F., Matsuda M., Essex M., Lee T. H. Open reading frame vpr of simian immunodeficiency virus encodes a virion-associated protein. J. Virol. 64:1990;5688-5693.
37. Zhao Y., Cao J., O'Gorman M. R. G., Yu M., Yogev R. Effect of human immunodeficiency virus type 1 protein R (vpr) gene expression on basic cellular function of fission yeastSchizosaccharomyces pombe. J. Virol. 70:1996;5821-5826.